Our Company

1 of 1
1-3 of 3
Commercial payers spend more on hospital outpatient drugs at 340B participating hospitals13 March 2018 - By Michael T. Hunter and Jason Gomberg and Carol Kim - Article

This report replicates portions of the 2015 U.S. Government Accountability Office 340B report (a comparison of the per Medicare beneficiary hospital pharmacy outpatient drug spending at 340B hospitals and non-340B hospitals) on a commercially insured population to determine if the relationships found in the Medicare population existed in the commercial markets.

Medicare Part D member profitability by pharmacy channel24 December 2015 - By Jason Gomberg and Michael T. Hunter - Article

An analysis of 2014 Part D plan profitability to determine if specific pharmacy channels are associated with members that may be more or less profitable for a Medicare Part D carrier.

Specialty Medical Drug 2010 Commercial Benchmark Study29 November 2012 - By Jamie Vora and Jason Gomberg - Article

What are the current costs and future cost trends for specialty drugs?

1 of 1

  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman